UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000024677
Receipt No. R000028391
Official scientific title of the study Safety of indocyanine green lymphography for evaluation of lymphedema
Date of disclosure of the study information 2016/11/02
Last modified on 2018/06/30 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Safety of indocyanine green lymphography for evaluation of lymphedema
Title of the study (Brief title) Indocyanine green lymphography for lymphedema
Region
Japan

Condition
Condition lymphedema
Classification by specialty
Plastic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Indocyanine green lymphography (ICG)is applied to clinical widely as a liver function test.These days, ICG is performed for evaluation of lymphedema as a preoperative examination.However, the side effects of ICG are not examined. Then, we perform ICG for lyphedema under medical treatment insurance adaptation outside (patient own expense) and evaluated the safety. Specifically, we carry out observation of whethe the general side effects (shock, nausea, blood vessel pain, fever)of ICG occur.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Check whether there are side effects (shock, nausea, blood vessel pain, fever)
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 We carry out local injection of ICG at dorsum of foot and the inside of foot joint intra- or subcutaneously. We trace the flow of ICG with an infrared observation camera. We carry out observation of whether side effects (shock, nausea, blood vessel pain, fever)happen.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The person by whom lymphedema continued three months or more and written consent was got.
Key exclusion criteria Those who have the past of hypersensitivity to iodine. Those who are judged that experimental participation is difficul by moral condition. A pregnant woman, a nursing mother. Moreover, those possible of pregnancy. The person to whom the doctor judged participation of the final examination to be unsuitable.
Target sample size 10

Research contact person
Name of lead principal investigator Kazuhiro Toriyama
Organization Nagoya City University Hospital
Division name Plastic and reconstructive surgery
Address 1-Kawasumi, MIzuho-cho, Mizuho-ku, Nagoya, Japan
TEL 052-858-7514
Email toriyama@med.nagoya-cu.ac.jp

Public contact
Name of contact person Takahumi Uchibori
Organization Nagoya City University Hospital
Division name Plastic and reconstructive surgery
Address 1-Kawasumi, MIzuho-cho, Mizuho-ku, Nagoya, Japan
TEL 052-858-7514
Homepage URL
Email uchibori83@gmail.com

Sponsor
Institute Nagoya city university hospital
Institute
Department

Funding Source
Organization Nagoya City University Hospital
Organization
Division
Category of Funding Organization Local Government
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 11 Month 02 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 10 Month 25 Day
Anticipated trial start date
2016 Year 11 Month 11 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 11 Month 02 Day
Last modified on
2018 Year 06 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028391